Pump Up the Protein Volume

exogenous proteins are often fatal to the cells, and endogenous proteins can interfere with purification of the target protein.

Written byMaria Anderson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Escherichia coli cells have long been protein-production factories for genetic engineers, but their capacity to generate single proteins has been hampered by two problems – exogenous proteins are often fatal to the cells, and endogenous proteins can interfere with purification of the target protein. Now, a group of researchers has developed a technique for producing large quantities of proteins in E. coli cells without having to worry about cytotoxicity or interference from background proteins. The single-protein production (SPP) system, designed by biochemist Masayori Inouye and his colleagues at the Robert Wood Johnson Medical School in New Jersey, allows scientists to manipulate E. coli to produce only a single target protein. The team found that this expression system works for human, yeast, and E. coli proteins.1

The SPP system exploits the properties of MazF, an E. coli toxin that works as an endoribonuclease, targeting single-stranded RNAs that include an ACA sequence. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies